All Stories

  1. Clinical features and outcomes in carriers of pathogenic desmoplakin variants

    Article • European Heart Journal, September 2024, Oxford University Press (OUP)

    Alexandros Protonotarios

  2. A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers

    Article • European Heart Journal, July 2024, Oxford University Press (OUP)

    Alexandros Protonotarios

  3. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy

    Article • EP Europace, November 2023, Oxford University Press (OUP)

    Alexandros Protonotarios

  4. Performance of the PRIMaCY sudden death risk prediction model for childhood hypertrophic cardiomyopathy: implications for implantable cardioverter-defibrillator decision-making

    Article • EP Europace, November 2023, Oxford University Press (OUP)

    Alexandros Protonotarios

  5. An mTORC1‐Dependent Mouse Model for Cardiac Sarcoidosis

    Article • Journal of the American Heart Association, October 2023, Wolters Kluwer Health

    Alexandros Protonotarios

  6. Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants

    Article • Circulation Genomic and Precision Medicine, October 2023, Wolters Kluwer Health

    Alexandros Protonotarios

  7. 2023 ESC Guidelines for the management of cardiomyopathies

    Article • European Heart Journal, August 2023, Oxford University Press (OUP)

    Alexandros Protonotarios

  8. Right ventricular function is a predictor for sustained ventricular tachycardia requiring anti-tachycardic pacing in arrhythmogenic ventricular cardiomyopathy: insight into transvenous vs. subcutaneous implantable cardioverter defibrillator insertion

    Article • EP Europace, May 2023, Oxford University Press (OUP)

    Alexandros Protonotarios

  9. Circulating c-Met–Expressing Memory T Cells Define Cardiac Autoimmunity

    Article • Circulation, December 2022, Wolters Kluwer Health

    Alexandros Protonotarios

  10. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator

    Article • European Heart Journal, June 2022, Oxford University Press (OUP)

    Alexandros Protonotarios

  11. Correction to: The genetic architecture of Plakophilin 2 cardiomyopathy

    Article • Genetics in Medicine, October 2021, Elsevier

    Alexandros Protonotarios

  12. The genetic architecture of Plakophilin 2 cardiomyopathy

    Article • Genetics in Medicine, October 2021, Elsevier

    Alexandros Protonotarios

  13. Evidence-Based Assessment of Genes in Dilated Cardiomyopathy

    Article • Circulation, July 2021, Wolters Kluwer Health

    Alexandros Protonotarios

  14. International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework

    Article • Circulation Genomic and Precision Medicine, June 2021, Wolters Kluwer Health

    Alexandros Protonotarios

  15. Myocardial strain analysis in family screening for genetic dilated cardiomyopathy: Testing the boundaries of normality?

    Article • International Journal of Cardiology, January 2021, Elsevier

    Alexandros Protonotarios

  16. An Evidence-based Assessment of Genes in Dilated Cardiomyopathy

    Article • December 2020, Cold Spring Harbor Laboratory Press

    Alexandros Protonotarios

  17. The novel desmin variant p.Leu115Ile is associated with a unique form of biventricular Arrhythmogenic Cardiomyopathy

    Article • Canadian Journal of Cardiology, December 2020, Elsevier

    Alexandros Protonotarios

  18. State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy

    Article • International Journal of Molecular Sciences, September 2020, MDPI AG

    Alexandros Protonotarios

  19. Influenza-associated cardiac injury: a disease of the cardiac conduction system?

    Article • Cardiovascular Research, June 2020, Oxford University Press (OUP)

    Alexandros Protonotarios

  20. Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype

    Article • International Journal of Cardiology, May 2020, Elsevier

    Alexandros Protonotarios

  21. Towards precision disease-modelling in experimental myocarditis

    Article • Cardiovascular Research, April 2020, Oxford University Press (OUP)

    Alexandros Protonotarios

  22. Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?

    Article • European Cardiology Review, February 2020, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Alexandros Protonotarios

  23. Short-term effects of angiotensin receptor-neprilysin inhibitors on diastolic strain and tissue doppler parameters in heart failure patients with reduced ejection fraction: A pilot trial

    Article • Hellenic Journal of Cardiology, December 2019, Elsevier

    Alexandros Protonotarios

  24. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study

    Article • European Heart Journal - Cardiovascular Imaging, July 2019, Oxford University Press (OUP)

    Alexandros Protonotarios

  25. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report

    Article • European Journal of Heart Failure, June 2019, Wiley

    Alexandros Protonotarios

  26. Left ventricular non-compaction: have we reached the limits of conventional imaging?

    Article • European Heart Journal, June 2019, Oxford University Press (OUP)

    Professor Perry M Elliott, Alexandros Protonotarios

  27. Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy

    Article • International Journal of Cardiology, June 2019, Elsevier

    Alexandros Protonotarios

  28. Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy

    Article • JAMA Cardiology, March 2019, American Medical Association (AMA)

    Alexandros Protonotarios

  29. Arrhythmogenic cardiomyopathies (ACs): diagnosis, risk stratification and management

    Article • Heart, February 2019, BMJ

    Alexandros Protonotarios

  30. OUP accepted manuscript

    Article • European Heart Journal, January 2019, Oxford University Press (OUP)

    Professor Domenico Corrado, Alexandros Protonotarios

  31. Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation

    Article • International Journal of Cardiology, November 2018, Elsevier

    Alexandros Protonotarios

  32. No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy

    Article • PLOS One, August 2018, PLOS

    Alexandros Protonotarios

  33. Genetic basis of arrhythmogenic cardiomyopathy

    Article • Current Opinion in Cardiology, March 2018, Wolters Kluwer Health

    Alexandros Protonotarios

  34. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells

    Article • Circulation Arrhythmia and Electrophysiology, February 2016, Wolters Kluwer Health

    Alexandros Protonotarios

  35. Clinical Significance of Epsilon Waves in Arrhythmogenic Cardiomyopathy

    Article • Journal of Cardiovascular Electrophysiology, September 2015, Wiley

    Alexandros Protonotarios

  36. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy

    Article • EP Europace, March 2015, European Society of Cardiology

    Alexandros Protonotarios

  37. Left dominant arrhythmogenic cardiomyopathy: A morbid association of ventricular arrhythmias and unexplained infero-lateral T-wave inversion

    Article • Journal of Electrocardiology, July 2013, Elsevier

    Alexandros Protonotarios

  38. Clear cell sarcoma of the jejunum: a case report

    Article • World Journal of Surgical Oncology, January 2013, Springer Science + Business Media

    Alexandros Protonotarios